相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups
Nawar Diar Bakerly et al.
RESPIRATORY MEDICINE (2019)
Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations
Diane Whalley et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2019)
A descriptive follow-up interview study assessing patient- centred outcomes: Salford Lung Study in Asthma (SLS Asthma)
Lynda Doward et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2019)
Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability
Ashley Woodcock et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study
Henrik Svedsater et al.
RESPIRATORY MEDICINE (2018)
Healthcare resource utilisation (HRU) in the Asthma Salford Lung Study (SLS asthma)
Dominy Browning et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect
Alexander Pate et al.
BMJ OPEN RESPIRATORY RESEARCH (2018)
Monitoring safety in a phase III real-world effectiveness trial: use of novel methodology in the Salford Lung Study
Sue Collier et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences
Katrien Oude Rengerink et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)
Series: Pragmatic trials and real world evidence: Paper 2. Setting, sites, and investigator selection
Sally D. Worsley et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)
Series: Pragmatic trials and real world evidence: Paper 1. Introduction
Mira G. P. Zuidgeest et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial
Ashley Woodcock et al.
LANCET (2017)
Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred
Lynda Doward et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2017)
Patient demographics and clinical characteristics in the UK Salford Lung Study (SLS COPD) and the European ACCESS study
Maurice Driessen et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups
Henrik Svedsater et al.
ADVANCES IN THERAPY (2017)
Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice
Jorgen Vestbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled bronchodilator therapy in COPD
Peter Kardos et al.
International Journal of Chronic Obstructive Pulmonary Disease (2016)
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
David M. G. Halpin et al.
RESPIRATORY RESEARCH (2016)
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
Tessa Kennedy-Martin et al.
TRIALS (2015)
The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma
Ashley Woodcock et al.
BMC PULMONARY MEDICINE (2015)
The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease
Nawar Diar Bakerly et al.
RESPIRATORY RESEARCH (2015)
Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study
Annemarije L. Kruis et al.
PLOS ONE (2014)
What Proportion of Chronic Obstructive Pulmonary Disease Outpatients Is Eligible for Inclusion in Randomized Clinical Trials?
Nicola Scichilone et al.
RESPIRATION (2014)
Randomized controlled trials and real life studies. Approaches and methodologies: a clinical point of view.
S. Saturni et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
Obtaining real-world evidence: the Salford Lung Study
John P. New et al.
THORAX (2014)
The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research
Kalipso Chalkidou et al.
CLINICAL TRIALS (2012)
Prospective Observational Studies to Assess Comparative Effectiveness: The ISPOR Good Research Practices Task Force Report
Marc L. Berger et al.
VALUE IN HEALTH (2012)
External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?
Justin Travers et al.
THORAX (2007)
How representative are clinical study patients with asthma or COPD for a larger real life population of patients with obstructive lung disease?
K Herland et al.
RESPIRATORY MEDICINE (2005)
分享论文
